Catalog: | C-FC-4798A |
Product Type: | FCM Antibody |
Size: | 5 µl(1µg)/test |
Reactivity: | Human |
Positive FC: | human peripheral blood lymphocytes |
Recommended dilution: | This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 µl(1µg) per 10^6 cells in a 100 µl suspension or 5 µl(1µg) per 100 µl of whole blood. |
Analysis mode: | FC |
Host: | Mouse |
Isotype: | IgG1 |
Alternate names: | CD279, hPD 1, hPD l, PD1, PDCD1, programmed cell death 1, Protein PD 1, SLEB2 |
Storage: | 2-8°C |
Purification method: | Affinity purification |
Immunogen: | N/A |
Genn_ID: | 5133 |
Gene accession: | BC074740 |
Gene symbol: | PDCD1 |
Buffer: | Phosphate based buffer with 0.09% sodium azide and 0.1% gelatin, pH 7.2. |
Programmed cell death 1 (PD-1, also known as CD279) is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a 288 amino acid (aa) type I transmembrane protein composed of one Ig superfamily domain, a stalk, a transmembrane domain, and an intracellular domain containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) as well as an immunoreceptor tyrosine-based switch motif (ITSM) (PMID: 18173375). PD-1 is expressed during thymic development and is induced in a variety of hematopoietic cells in the periphery by antigen receptor signaling and cytokines (PMID: 20636820). Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function (PMID: 19426218). It is critical for the regulation of T cell function during immunity and tolerance. Blockade of PD-1 can overcome immune resistance and also has been shown to have antitumor activity (PMID: 22658127; 23169436).
Copyright © 2025 Creative Biogene. All rights reserved.